The Pandemic and Bio Defense fund is intended to accelerate innovation in an area that has aroused widespread concern, particularly due to the spread of the avian flu in Asia, Africa and now Europe. 'There's been a dearth of innovation around infectious disease,' said Kleiner Perkins partner Brook Byers. 'We want more people to pay attention to this problem.'"
Thursday, February 16, 2006
KPCB and BCRX - Forbes.com
"Silicon Valley powerhouse venture capital firm Kleiner Perkins Caufield & Byers is delving into new territories: bio-defense, infectious disease and clean technologies. The 30-year-old firm, which has traditionally invested in information technology and life science companies, announced today that it has already raised money for two new funds--a $200 million Pandemic and Bio Defense Fund, and a $100 million Green Technologies fund. It's already made one investment with its bio-defense fund and five investments in the Green Techologies fund.
The Pandemic and Bio Defense fund is intended to accelerate innovation in an area that has aroused widespread concern, particularly due to the spread of the avian flu in Asia, Africa and now Europe. 'There's been a dearth of innovation around infectious disease,' said Kleiner Perkins partner Brook Byers. 'We want more people to pay attention to this problem.'"
The Pandemic and Bio Defense fund is intended to accelerate innovation in an area that has aroused widespread concern, particularly due to the spread of the avian flu in Asia, Africa and now Europe. 'There's been a dearth of innovation around infectious disease,' said Kleiner Perkins partner Brook Byers. 'We want more people to pay attention to this problem.'"
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment